Please login to the form below
Dementia Discovery Fund
This page shows the latest Dementia Discovery Fund news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance
The Dementia Discovery Fund (DDF) confirmed yesterday that it had raised £250m ($350m), boosted by a $60m investment from US non-profit organisation AARP, which aims to help older people live ... The fundraising far exceeded its initial target of $200m (
Latest news
-
British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
A new UK government-backed investment vehicle to provide long-term capital for British businesses has been launched, with a fund backing dementia drug developers among the first to benefit. ... The Dementia Discovery Fund is one of two VCs given funding
-
Pfizer drops neuroscience R&D, cutting 300 jobs
It will also set up a dedicated venture capital fund to invest in other companies carrying out neuroscience R&D and “support continued efforts to advance the field”. ... Pfizer is already one of the founder members of the cross-company Dementia
-
Woodford investment pushes Dementia Discovery Fund to £100m
Fund aims to back 40 projects over its 15-year term. Thanks to a £15m pledge from Neil Woodford's investment group, the public-private Dementia Discovery Fund (DDF) has now ... therapies. The DDF's chief scientific officer - former Takeda drug discovery
-
GSK and J&J back new UK dementia discovery fund
Pharma giants collaborate with government to find new treatments. GlaxoSmithKline, Johnson &Johnson and Pfizer have signed up to support a new UK government dementia discovery fund. ... The fund will work with universities, academic institutes and the
-
Freeman: More pharma-charity research partnerships needed
Similar partnerships have been launched in recent years for conditions, including dementia and Parkinson's disease - both areas of significant unmet medical need. ... Earlier this year, Lilly, Pfizer, GlaxoSmithKline, Biogen Idec and Johnson &Johnson
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 2)
In the meantime, she is challenging not just the accepted ways of conducting drug discovery, but also some of the male behaviour that can mar the working environment. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment
-
The world is our laboratory
This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This was set up in 2013 to identify innovative solutions for dementia care.
-
Pharma deals in March 2015
This month saw GSK invest $25m, J&J $10m and the UK Government $22m into the Dementia Discovery fund, a joint initiative also including Lilly, Biogen and Pfizer to research treatments
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Forecasting in Forgotten Markets
To help address a lack of investment in novel dementia science a new £100M Dementia Discovery Fund ( ) was launched towards the end of last year. ... Managed by SV Life Sciences the fund is focused primarily on Phase I and II research and aims to help
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Digital Account Director
-
Salary TBC
Subscribe to our email news alerts
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- 2019: CRISPR and therapeutic gene editing comes of age
- Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
- The 10-year Web Challenge
- Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
- Downloadable Pack: Understanding Multiple Sclerosis
- Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Quick links
Infographics
